Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Kassner

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Der Internist|May 19, 2017
[Severe hypertriglyceridemia : Diagnostics and new treatment principles]U Kassner, M Dippel, E Steinhagen-Thiessen
International Journal of Rheumatology|January 11, 2013
A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and AtherosclerosisI Missala, U Kassner, E Steinhagen-Thiessen
Current Medical Research and Opinion|February 10, 2006
Evaluation of the safety and tolerability of prolonged-release nicotinic acid in a usual care setting: the NAUTILUS studyA Vogt, U Kassner, U Hostalek, et al.
International Journal of Clinical Practice|October 16, 2007
Correction of low HDL cholesterol to reduce cardiovascular risk: practical considerations relating to the therapeutic use of prolonged-release nicotinic acid (Niaspan)A Vogt, U Kassner, U Hostalek, et al.
The International Journal of Artificial Organs|November 4, 2000
DALI LDL-apheresis: anticoagulation with r-hirudin in a patient with heparin-induced thrombocytopenia (HIT II)H P Thomas, U Kassner, C Schliesser, et al.
Atherosclerosis|April 11, 2016
A lipidomic analysis approach in patients undergoing lipoprotein apheresisC Schmöcker, U Kassner, S Kiesler, et al.
Atherosclerosis. Supplements|February 5, 2010
Designing a study to evaluate the effect of apheresis in patients with elevated lipoprotein(a)U Kassner, A Vogt, A Rosada, et al.
Atherosclerosis. Supplements|November 4, 2017
Effect of different lipid apheresis methods on plasma polyunsaturated fatty acidsC Schmöcker, U Kassner, A I Ostermann, et al.
Clinical Laboratory|May 20, 2026
Impact of Lipoprotein (a) on the Quantification of LDL-CholesterolS Drobnik, A Koloi, H Scharnagl, et al.
Zeitschrift Fur Kardiologie|December 10, 2003
[Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]M Suckfüll, D Seidel, J Thiery, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Der Internist|May 19, 2017
[Severe hypertriglyceridemia : Diagnostics and new treatment principles]U Kassner, M Dippel, E Steinhagen-Thiessen
International Journal of Rheumatology|January 11, 2013
A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and AtherosclerosisI Missala, U Kassner, E Steinhagen-Thiessen
Current Medical Research and Opinion|February 10, 2006
Evaluation of the safety and tolerability of prolonged-release nicotinic acid in a usual care setting: the NAUTILUS studyA Vogt, U Kassner, U Hostalek, et al.
International Journal of Clinical Practice|October 16, 2007
Correction of low HDL cholesterol to reduce cardiovascular risk: practical considerations relating to the therapeutic use of prolonged-release nicotinic acid (Niaspan)A Vogt, U Kassner, U Hostalek, et al.
The International Journal of Artificial Organs|November 4, 2000
DALI LDL-apheresis: anticoagulation with r-hirudin in a patient with heparin-induced thrombocytopenia (HIT II)H P Thomas, U Kassner, C Schliesser, et al.
Atherosclerosis|April 11, 2016
A lipidomic analysis approach in patients undergoing lipoprotein apheresisC Schmöcker, U Kassner, S Kiesler, et al.
Atherosclerosis. Supplements|February 5, 2010
Designing a study to evaluate the effect of apheresis in patients with elevated lipoprotein(a)U Kassner, A Vogt, A Rosada, et al.
Atherosclerosis. Supplements|November 4, 2017
Effect of different lipid apheresis methods on plasma polyunsaturated fatty acidsC Schmöcker, U Kassner, A I Ostermann, et al.
Clinical Laboratory|May 20, 2026
Impact of Lipoprotein (a) on the Quantification of LDL-CholesterolS Drobnik, A Koloi, H Scharnagl, et al.
Zeitschrift Fur Kardiologie|December 10, 2003
[Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]M Suckfüll, D Seidel, J Thiery, et al.
Pageof 2